Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Azorsa

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|August 20, 2010
RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cellsShilpi Arora, Kristen M Bisanz, Lourdes A Peralta, et al.
Molecular Cancer|August 20, 2010
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcomaShilpi Arora, Irma M Gonzales, R Tanner Hagelstrom, et al.
Molecular Cancer Research : MCR|May 4, 2011
High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cellsMeredith C Henderson, Irma M Gonzales, Shilpi Arora, et al.
Pediatric Blood & Cancer|May 17, 2018
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosisDavid O Azorsa, David W Lee, Daniel H Wai, et al.
Chemical Biology & Drug Design|March 25, 2010
Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cellsChristine Kaiser, Nathalie Meurice, Irma M Gonzales, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|October 12, 2012
Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancerSara A Byron, Elizabeth Min, Tanya S Thal, et al.
Cancer Research|July 29, 2010
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancerLiang Cao, Yunkai Yu, Sven Bilke, et al.
Plos One|April 13, 2011
NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cellsSevtap Savas, David O Azorsa, Hamdi Jarjanazi, et al.
BMC Cancer|December 29, 2019
In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cellsJustin J Montoya, Megan A Turnidge, Daniel H Wai, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|August 20, 2010
RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cellsShilpi Arora, Kristen M Bisanz, Lourdes A Peralta, et al.
Molecular Cancer|August 20, 2010
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcomaShilpi Arora, Irma M Gonzales, R Tanner Hagelstrom, et al.
Molecular Cancer Research : MCR|May 4, 2011
High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cellsMeredith C Henderson, Irma M Gonzales, Shilpi Arora, et al.
Pediatric Blood & Cancer|May 17, 2018
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosisDavid O Azorsa, David W Lee, Daniel H Wai, et al.
Chemical Biology & Drug Design|March 25, 2010
Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cellsChristine Kaiser, Nathalie Meurice, Irma M Gonzales, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|October 12, 2012
Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancerSara A Byron, Elizabeth Min, Tanya S Thal, et al.
Cancer Research|July 29, 2010
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancerLiang Cao, Yunkai Yu, Sven Bilke, et al.
Plos One|April 13, 2011
NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cellsSevtap Savas, David O Azorsa, Hamdi Jarjanazi, et al.
BMC Cancer|December 29, 2019
In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cellsJustin J Montoya, Megan A Turnidge, Daniel H Wai, et al.
Pageof 3